III 110th CONGRESS 1st Session S. RES. 382 IN THE SENATE OF THE UNITED STATES November 14, 2007 Ms. Stabenow (for herself, Mr. Domenici, Mr. Lautenberg, and Mr. Coleman) submitted the following resolution; which was considered and agreed to RESOLUTION Supporting the goals and ideals of World Diabetes Day.

Whereas the World Health Organization and the International Diabetes Federation established World Diabetes Day in 1991 with the aim of coordinating diabetes advocacy worldwide; Whereas World Diabetes Day is celebrated annually on November 14; Whereas, on December 20, 2006, the General Assembly of the United Nations passed a landmark resolution recognizing diabetes as a chronic, debilitating, and costly disease; Whereas the resolution designates World Diabetes Day as a United Nations Day to be observed every year starting in 2007 in order to raise global awareness of diabetes; Whereas the theme of the 2007 United Nations World Diabetes Day campaign focuses on raising awareness of diabetes in children and adolescents, who face unique challenges when diagnosed with diabetes; Whereas the United Nations campaign aims, among other objectives, to firmly establish the message that no child should die of diabetes; Whereas the global diabetes epidemic has devastating effects on families, societies, and national economies; Whereas diabetes is the 4th leading cause of death by disease in the world, and is the 6th leading cause of death in the United States; Whereas diabetes is a leading cause of blindness, kidney failure, amputation, heart attack, and stroke; Whereas in almost every country the incidence of diabetes is increasing, growing from an estimated 30,000,000 people worldwide in 1985 to an estimated 245,000,000 people in 2007, and to 380,000,000 by 2025, as reported by the International Diabetes Federation; Whereas diabetes is one of the most common chronic childhood diseases; Whereas diabetes can strike children at any age, and when diagnosed in young people the risk of developing life-threatening complications at an early age increases and life expectancy is shortened by, on average, 10 to 20 years; Whereas new figures from the International Diabetes Federation’s Diabetes Atlas suggest that more than 70,000 children develop type 1 diabetes each year and 440,000 children worldwide under the age of 14 now live with type 1 diabetes; Whereas recent data indicate that 1 out of every 3 children born in the United States will develop diabetes during their lifetime, including 1 out of every 2 children from ethnic minority groups; Whereas in low- and middle-income countries, many children with diabetes die because they are diagnosed late or misdiagnosed or because insulin is unaffordable, unavailable, or in short supply; Whereas the incidence of type 2 diabetes, which was previously rare in children, is rising at alarming rates, with more than 200 children a day developing this form of diabetes; Whereas obesity is a major contributor to type 2 diabetes; Whereas according to the International Obesity Task Force of the International Association for the Study of Obesity, 155,000,000 school-age children worldwide are overweight, representing at least 1 out of every 10 school-age children; Whereas at least 30,000,000 of those overweight children are classified as obese, accounting for at least 2 percent of the world’s children between the ages of 5 and 17 years of age; Whereas research has shown conclusively that type 2 diabetes can be prevented or significantly delayed through healthy weight maintenance and regular physical activity; Whereas adopting a lifestyle high in physical activity and adopting a low-sugar, low-fat diet can successfully prevent the onset of obesity and diabetes among school-age children; Whereas diabetes is costly, with the world estimated to spend at least $232,000,000,000 in 2007 and over $302,500,000,000 by 2025 to treat and prevent diabetes and its complications; Whereas world treatment costs for diabetes are growing more quickly than the world population; Whereas diabetes threatens to subvert global economic advancement by both straining government budgets worldwide (with the cost of diabetes-related disability payments, pensions, social and medical service costs, and lost revenue) and burdening private health insurers and employers with spiraling health care costs; Whereas by 2025 the largest increases in diabetes prevalence will take place in developing countries, whose economies are less able to support increased expenditures to provide for those with the disease and engage in effective prevention efforts; and Whereas the economic impact of diabetes threatens to undermine the achievement of the United Nation’s Millennium Development Goals for developing countries: Now, therefore, be it

That the Senate supports the goals and ideals of World Diabetes Day.